BioPharma Media

Biopharmaceutical industry analysis.
Credible, reliable, equitable.

[BioPharma Media @BiopharmaMedia]

New drugs for #HighBloodPressure can be administered monthly, quarterly, or even semi-annually. #Zilebesiran and #tonlamarsen — fast, reliable, expensive! #hypertension #Alnylam #Ionis #Roche #evazarsen #RNAi
https://t.co/YVDYzWO4UW

[BioPharma Media @BiopharmaMedia]

#Nexsheld (#sipavibart) effectively prevents #COVID19 in those who cannot be vaccinated. Nexsheld is #PrEP and updated version of #Evusheld that takes into account new #SARSCoV2 variants. #COVID19PrEP #AstraZeneca https://t.co/kIpR60PXaj

[BioPharma Media @BiopharmaMedia]

#Baxdrostat by #CinCor Pharma is nice addition to existing armamentarium of hypotensive drugs, which has not been updated for many years. Baxdrostat solves big problem of #highbloodpressure in resistant or uncontrolled #hypertension $CINC
https://t.co/TFXBIsh5NY

[BioPharma Media @BiopharmaMedia]

#Relyvrio / #Albrioza by #Amylyx Pharmaceuticals reduces risk of death by 44%. Considering median survival rate for #ALS is ~4 years from symptom onset, continued administration of Relyvrio/Albrioza can extend life to 6–6.5 years. $AMLX https://t.co/0dbVYSmv0e

[BioPharma Media @BiopharmaMedia]

#Skysona (#ElivaldogeneAutotemcel) is a #genetherapy to cure cerebral adrenoleukodystrophy (#CALD). Skysona, developed by #BluebirdBio, is used once. Skysona’s cost in U.S. is set at $3 million. $BLUE #adrenoleukodystrophy #newdrug
https://t.co/j3ipXb5DP1

[BioPharma Media @BiopharmaMedia]

Lower respiratory tract #infections (#LRTI) caused by respiratory syncytial virus (#RSV) are often fatal for infants. One injection of #Beyfortus (#nirsevimab) by #AstraZeneca and #Sanofi will keep babies safe throughout entire RSV season. #NewDrug
https://t.co/MohgwvN9RO

[BioPharma Media @BiopharmaMedia]

Oral #Sotyktu (#deucravacitinib) is new effective drug to treat #plaquepsoriasis. Sotyktu will rid 2/3 of patients of #psoriasis in 1 year of treatment. Sotyktu costs $6,200 per month, or $74,000 per year. $BMY
https://t.co/W1Tl9PcvAw

[BioPharma Media @BiopharmaMedia]

#Albrioza for #ALS costs C$17,776 ($13,219) per month, or C$206,000 ($159,000) per year. By comparison, annual ALS treatment with #Radicava costs about C$120,000 ($92,500) in Canada and $175,000 in the US. #Amylyx #drugprice
https://t.co/0dbVYSmv0e

[BioPharma Media @BiopharmaMedia]

Which antiviral drugs and monoclonal antibodies work effectively against #Omicron variant of #SARSCoV2 #coronavirus? #COVID19 should only be treated with effective #drugs. #pandemic
https://t.co/yOdls1vG96

[BioPharma Media @BiopharmaMedia]

#Tecvayli (#teclistamab) by #Janssen of #JnJ is a powerful #newdrug for advanced #MultipleMyeloma that has stopped responding to standard therapy and is progressing. Tecvayli prolongs patients’ lives.
https://t.co/mRhITFYI35

[BioPharma Media @BiopharmaMedia]

Bacillus Calmette-Guérin (#BCG) #vaccine provided 100% protection against #COVID19. BCG, which organizes broad immunity, protects against any #SARSCoV2 #coronavirus mutation, including #Omicron.
https://t.co/h00n0La1iW

[BioPharma Media @BiopharmaMedia]

#Auvelity (#dextromethorphan + #bupropion) by #Axsome Therapeutics is new oral drug for #MajorDepressiveDisorder (#MDD) in adults. Auvelity (#AXS05) has rapid and prolonged therapeutic effects. $AXSM #antidepressant #antidepressants #depression
https://t.co/638cNqy1pv

[BioPharma Media @BiopharmaMedia]

If #ensifentrine by #VeronaPharma for #COPD maintenance therapy can help those patients who are already on dual (LAMA/LABA) or triple (LAMA/LABA/ICS) treatment regimen, a truly sought-after drug awaits. $VRNA #Wynayre #Wynfidra
https://t.co/9Ink9BAHdo

[BioPharma Media @BiopharmaMedia]

#Qalsody (#tofersen) is the first and only drug for amyotrophic lateral sclerosis (#ALS) with superoxide dismutase 1 (#SOD1) gene mutation. #Biogen #Ionis $BIIB $IONS
https://t.co/Fz4gwFj8LY

[BioPharma Media @BiopharmaMedia]

#InsulinIcodec by #NovoNordisk is ultra-long acting basal #insulin injected subcutaneously once a week. #EliLilly works on weekly #InsulinEfsitoraAlfa (#LY3209590). #diabetes #diabetesmellitus #Awiqli #Aweeqli #Simwekli #Wunzeek #Bemrelfy #Iwelby #Onwelby
https://t.co/TEYuiCV00K

[BioPharma Media @BiopharmaMedia]

#Doxycycline #PrEP after unprotected intercourse reduced risk of sexually transmitted infections (#STI) by 65%. #Gonorrhea ↓ 56%, #chlamydia ↓ 81%, #syphilis ↓ 82%. Awesome! #HIV #AIDS
https://t.co/7Sk6qR5gtY

[BioPharma Media @BiopharmaMedia]

#Zoryve (#roflumilast) by #Arcutis Biotherapeutics is new cream for #psoriasis treating of any severity including in adolescents and in sensitive intertriginous areas. Zoryve is safe and as effective as potent topical corticosteroids. @ArcutisBio $ARQT
https://t.co/sNzLOaeuek

[BioPharma Media @BiopharmaMedia]

#Vuity by #Allergan/#AbbVie is the first drug to treat #presbyopia (age-related farsightedness). What is the difference between Vuity and generic #pilocarpine? $ABBV
https://t.co/1HnGfm9UX6

[BioPharma Media @BiopharmaMedia]

On July 29, 2022, #Amylyx announced the commercial availability of #Albrioza in #Canada. The #NewDrug for #AmyotrophicLateralSclerosis treatment went on sale at full price. #ALS $AMLX
https://t.co/0dbVYSmv0e

[BioPharma Media @BiopharmaMedia]

#Bepirovirsen by #GlaxoSmithKline is antisense oligonucleotide (#ASO) that could functionally cure chronic hepatitis B (#CHB) #infection. Interim results are impressive. Critics claim that ASOs are fundamentally flawed. #hepatitisB #hepatitis
https://t.co/UF7eiIkLqU